Status:
COMPLETED
Companion: Sensor-based Two-way Communication for Physical Activity in Older Adults
Lead Sponsor:
Northeastern University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Exercise
Physical Activity
Eligibility:
All Genders
60-90 years
Phase:
EARLY_PHASE1
Brief Summary
This pilot study is a small sample (N=46) 16-week clinical trial with a follow-up after 24-weeks among sedentary adults \>60 y with a BMI \>25 kg/m2 to tests the impact of a hybrid artificial intellig...
Detailed Description
This is a single site randomized clinical trial to test if if Companion improves and sustains free-living physical activity and sedentary behaviors in adults \>60 y and improves health outcomes. Forty...
Eligibility Criteria
Inclusion
- Age 60 years and above- This intervention study focusses on this population demographic.
- Participants have a body mass index greater than 25 kg/m2- This threshold for BMI is used to classify an adult as overweight or obese
- No conditions preventing participation in physical activity lasting 10 to 30 min- Such conditions will limit prescription of physical activity/exercise components of the training program and that promoted using Companion.
- Have a smart phone- The absence of a smart phone will limit the ability of remote communication with the study participant using Companion.
Exclusion
- Engage in structured physical activity for more than 2 days/week lasting 30 min/session- Physically active participants will not be representative of typical adults \>60 y. Being active prior to study participation may mask the effects of the intervention.
- Regularly use any assistive device for walking- Use of an assistive device would limit the ability to engage in prescribed physical activity. Future work can be tailored for sub-groups in the demographic being studied.
- Likely to alter medications pertaining to cardiovascular or metabolic health- Altering medications during the study will influence change in selected outcome measures.
Key Trial Info
Start Date :
March 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04827212
Start Date
March 16 2021
End Date
December 13 2022
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northeastern Univeristy
Boston, Massachusetts, United States, 02115